Arlington Trust »

Nektar Therapeutics shares owned by Arlington Trust

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Arlington Trust from 13F filings

Historical chart of Arlington Trust investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Arlington Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Arlington Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $340 6 56.83
2025-06-30 $154 6 25.83

More positions owned by Arlington Trust

Vanguard Total Stock Market ETF (VTI)
Vanguard High Dividend Yield ETF (VYM)
Vanguard Europe Pacific ETF (VEA)
Vanguard Dividend Appreciation ETF (VIG)
Vanguard Int High Dvd Yld In exchange traded funds (VYMI)
Invesco S&p 500 Equal Weight Etf (RSP)
Apple (AAPL)
Schwab Strategic Tr us lrg cap etf (SCHX)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
Spdr S&p 500 Etf (SPY)
iShares S&P 500 Value Index (IVE)
NVIDIA Corporation (NVDA)
Proshares Tr russ 2000 divd (SMDV)
Alphabet Inc Class A cs (GOOGL)

View all positions for Arlington Trust

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics